![]() |
MK-4827 drug candidate shows promising anti-tumour activity in first human trial
A new drug that targets proteins responsible for helping cancer cells to repair damage to their DNA has shown promising anti-tumour activity in its first trial in humans.
More... |
| All times are GMT -7. The time now is 03:01 PM. |
Powered by vBulletin® Version 3.8.7
Copyright ©2000 - 2026, vBulletin Solutions, Inc.
Copyright HER2 Support Group 2007 - 2021